Jigar Patel is founder and CEO of Nimble Therapeutics. With more than 15 years of experience in the pharmaceutical and biotechnology space, Jigar leads Nimble’s veteran team and champions the company’s game-changing technology for accelerating the discovery and development of peptide therapeutics.
Jigar started his drug development career at the Walter Reed Institute of Research supporting a Vaccine and Drug trial for Malaria in Western Kenya. Before founding Nimble, Jigar led an early discovery research team at Roche with collaborations globally with diagnostic and therapeutics divisions across many disease areas. Jigar is an author and inventor on numerous peer reviewed publications and patents in the areas of drug discovery, oncology, immunology and infectious disease. Jigar was trained at Dr. MGR Medical University and at the University of Notre Dame.
